Cargando…
The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells
PIKfyve is an evolutionarily conserved lipid and protein kinase enzyme that has pleiotropic cellular functions. The aim of the present study was to investigate the effects of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) inhibitor, YM201636, on nonsmall cell lung cancer (NSCLC) cells growth, t...
Autores principales: | DOĞAN, Eda, DÜZGÜN, Zekeriya, YILDIRIM, Zafer, ÖZDİL, Berrin, AKTUĞ, Hüseyin, BOZOK ÇETİNTAŞ, Vildan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877718/ https://www.ncbi.nlm.nih.gov/pubmed/33597819 http://dx.doi.org/10.3906/biy-2010-32 |
Ejemplares similares
-
The PIKfyve Inhibitor YM201636 Blocks the Continuous Recycling of the Tight Junction Proteins Claudin-1 and Claudin-2 in MDCK cells
por: Dukes, Joseph D., et al.
Publicado: (2012) -
Inhibition of PIKfyve by YM-201636 Dysregulates Autophagy and Leads to Apoptosis-Independent Neuronal Cell Death
por: Martin, Sally, et al.
Publicado: (2013) -
Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016) -
Case-control study on PCSK9 R496W (rs374603772) and D374Y (rs137852912) mutations in Turkish patients with primary dyslipidemia
por: Eroğlu, Zuhal, et al.
Publicado: (2018) -
Histopathological and molecular analysis in dermis and epidermis of patients with systemic and localized scleroderma
por: Sozeri, Betul, et al.
Publicado: (2014)